FH Advocate for Awareness, Allison Jamison, joined FH Foundation Scientific Advisory Board Member Dr. James Underberg (Clinical Assistant Professor of Medicine NYU Medical School & NYU Center for CV Prevention, Director Bellevue Hospital Lipid Clinic, President-Elect NLA) to speak about her experience … Read More →
Author Archives: Marie Louise Brumit
FH Awareness Day (est. 2012) is a campaign initiated by the FH Foundation to raise awareness of FH in the general public. This annual event is held on the September 24th, during National Cholesterol Education Month. Previous FH Awareness Day campaigns consisted of community outreach through local Patient … Read More →
Information is the coin of the realm in biopharmaceuticalsâ€”but what will it take to make the vast reams of data now being generated in the transactional tsunami of modern healthcare truly useful to its users? To help answer this question, Pharm Exec recently hosted an editorial Roundtable.
Key … Read More →
Today is National Wear Red Day – a day where we unite to raise awareness of heart disease and stroke. Read why Tom, a father living with familial hypercholesterolemia goes RED:
Why do I wear Red today?
This is me on my LDL apheresis machine at the Reading Hospital. I have been doing this … Read More →
The FH Specific Diagnosis Codes are on Track for October 2016The transition to ICD-10 has begun and you might be wondering why there are still no International Classification of Diseases (ICD) codes specifically for familial hypercholesterolemia (FH). The answer is that we are still waiting for the … Read More →
The FH Foundation is working to ensure your voice, backed up by clinical and real world data, is heard loud and clear in conversations that impact your health. We are working with patients, doctors, nurse practitioners, policy makers, drug manufacturers and payers to make sure Familial Hypercholesterolemia … Read More →
I was diagnosed with familial hypercholesterolemia (FH) at 29. Like many FH patients, I had never heard of the disorder before my diagnosis. But as I learned more about FH, it was obvious that this disorder has been a part my family’s life for generations.My dad had his first heart attack at age 36. … Read More →
September 30, 2015 6:30 PM – 9:00 PM
The ACC is offering a series of CME courses on FH across the U.S. and the FH Foundation is proud to be a part of this effort. On September 30 in Washington, DC, join nationally recognized experts, Samuel Gidding, MD and Alan … Read More →
Photo (left to right): Dr. Anne Goldberg, Dr. Seth Baum, Mackenzie AmesAn engaged gathering of medical professionals met for the Florida Chapter of The American College of Cardiology’s continuing medical education series on FH last week. This is the second in a series of eight CME lectures the … Read More →
Amgen’s PCSK9 inhibitor, Repatha (evolocumab), has been approved today by the U.S. Food and Drug Administration (FDA).We all have the chance to prevent early heart disease for over a million Americans, just by saying the words “familial hypercholesterolemia.” Until recently, virtually no one … Read More →